CRISIL Q2 FY26 (CONS.)

Net Profit: ₹204.54 Cr ↑5.92% YoY | ↓5.46% QoQ

Revenue: ₹1,095.16 Cr ↑20.18% YoY | ↑1.84% QoQ

EBITDA: ₹327.90 Cr ↑3.25% YoY | ↓1.32% QoQ

EBITDA Margin: 29.94% vs 34.85% YoY | 30.90% QoQ

SBI Funds Management Ltd – Q2 FY27 FINANCIAL RESULTS HIGHLIGHTS

Investor presentation for the quarter and half year ended September 30, 2026:

- MF QAAUM: INR 13,140 bn (15.0% market share)

- Passive QAAUM: INR 4,152 bn (27.4% market share)

- AIF QAAUM: INR 7437 Cr (up 27% YoY)

- SIP AUM: INR 2,070 bn (up 15% YoY)

- H1 FY27 Operating Income: INR 2336 Cr (up 12% YoY)

- H1 FY27 Operating Profit: INR 1797 Cr (up 11% YoY)

DR REDDY'S LABS Q2 FY27 (CONS.)

Net Profit: ₹913 Cr ↓31.71% YoY | ↑109.40% QoQ

Revenue: ₹8,698 Cr ↓1.47% YoY | ↑7.38% QoQ

EBITDA: ₹1,731 Cr ↓13.88% YoY | ↑101.28% QoQ

EBITDA Margin: 19.90% vs 22.77% YoY | 10.62% QoQ

Dr Reddys Laboratories Ltd – Q2FY27 FINANCIAL RESULTS UPDATE

Financial highlights for the quarter ended September 2026:

- Reported Revenues: INR 8671 Cr (up 1.5% YoY, 7% QoQ)

- EBITDA: INR 1783 Cr (up 24% YoY, 77% QoQ) at 20.6% margin

- PBT: INR 1228 Cr (up 33% YoY, 122% QoQ)

- PAT: INR 925 Cr (up 36% YoY, 109% QoQ)

- Net Cash surplus: INR 2502 Cr

- CDMO business (Aurigene): Surpassed $100 million in revenues for 12 months ended Sep'26

Dr Reddys Laboratories Ltd – APPOINTMENT OF SENIOR MANAGEMENT PERSONNEL

Appointment of new Head API and Services effective November 13, 2026:

- Mr. Akhil Ravi appointed as Head API and Services and Senior Management Personnel

- Mr. Akhil Ravi inducted as a Member of the Management Council

- He will continue to lead operations of Aurigene Pharmaceutical Services Ltd (wholly owned subsidiary)

- Mr. Akhil Ravi brings nearly 19 years of experience in strategy and commercial leadership

- He currently serves as CEO of Aurigene Pharmaceutical Services Ltd

GEOJIT FINANCIAL SERVICES Q2 FY27 (CONS.)

Net Profit: ₹16.28 Cr ↓30.62% YoY | ↓17.87% QoQ

Revenue: ₹165.82 Cr ↑2.56% YoY | ↑3.38% QoQ

EBITDA: ₹30.34 Cr ↓1.57% YoY | ↓4.41% QoQ

EBITDA Margin: 18.30% vs 19.06% YoY | 19.79% QoQ

RAMCO SYSTEMS Q2 FY27

Net Profit: ₹0.5 Cr ↓96% YoY | ↓20% QoQ

Revenue: ₹182 Cr ↑4% YoY | ↑5% QoQ

EBITDA: ₹26 Cr ↓34% YoY | ↑1% QoQ

EBITDA Margin: 14.2% vs 22.4% YoY | 14.7% QoQ

SHAKTI PUMPS Q2 FY27

Net Profit: ₹39 Cr ↓58% YoY | ↓25% QoQ

Revenue: ₹746 Cr ↑12% YoY | ↓13% QoQ

EBITDA: ₹64 Cr ↓53% YoY | ↓23% QoQ

EBITDA Margin: 8.6% vs 20.4% YoY | 9.6% QoQ

RUNWAL ENTERPRISES Q1 FY27 (CONS.)

Net Profit: ₹49.76 Cr ↓65.21% YoY | ₹62.02 Cr loss QoQ

Revenue: ₹338.16 Cr ↓24.21% YoY | ↑60.29% QoQ

EBITDA: ₹66.43 Cr ↓57.82% YoY | ₹39.74 Cr loss QoQ

EBITDA Margin: 19.65% vs 35.30% YoY | -18.84% QoQ

SHIVA CEMENT Q2 FY27

Net Loss: ₹22.85 Cr vs ₹32.73 Cr loss YoY | ₹21.35 Cr loss QoQ

Revenue: ₹112.70 Cr ↑37.25% YoY | ↓25.61% QoQ

EBITDA: ₹17.31 Cr ↑331.45% YoY | ↓7.19% QoQ

EBITDA Margin: 15.36% vs 4.89% YoY | 12.31% QoQ

SBI FUNDS MANAGEMENT Q2 FY27 (CONS.)

Net Profit: ₹7,012.44 Cr ↓5.99% YoY | ↓20.34% QoQ

Revenue: ₹11,926.72 Cr ↑8.91% YoY | ↑3.47% QoQ

EBITDA: ₹9,126.91 Cr ↑5.41% YoY | ↓1.11% QoQ

EBITDA Margin: 76.52% vs 79.07% YoY | 80.07% QoQ

TRUALT BIOENERGY Q2 FY27 (CONS.)

Net Profit: ₹34.99 Cr vs ₹37.94 Cr loss YoY | ↓40.96% QoQ

Revenue: ₹811.10 Cr ↑606.17% YoY | ↑29.39% QoQ

EBITDA: ₹101.16 Cr vs ₹4.55 Cr loss YoY | ↓23.80% QoQ

EBITDA Margin: 12.47% vs -3.96% YoY | 21.18% QoQ

SUPREME PETROCHEM Q2 FY27

Net Profit: ₹97 Cr ↑100% YoY | ↓59% QoQ

Revenue: ₹1,984 Cr ↑77% YoY | ↑16% QoQ

EBITDA: ₹152 Cr ↑93% YoY | ↓54% QoQ

EBITDA Margin: 7.7% vs 7.0% YoY | 19.4% QoQ

UTI AMC Q2 FY27

Net Profit: ₹132 Cr Flat YoY | ↓55% QoQ

Revenue: ₹415 Cr ↓1% YoY | ↓29% QoQ

EBITDA: ₹191 Cr ↑8% YoY | ↓50% QoQ

EBITDA Margin: 46.2% vs 42.3% YoY | 65.6% QoQ

BPCL Q2 FY27

Net Profit: ₹4,993 Cr vs ₹3,962 Cr loss QoQ | ↓22% YoY

Revenue: ₹1.49 lakh Cr ↑41% YoY | ↓2% QoQ

EBITDA: ₹9,571 Cr vs ₹2,857 Cr loss QoQ | ↓12% YoY

EBITDA Margin: 6.4% vs 10.2% YoY | -1.87% QoQ

HYPERSOFT TECHNOLOGIES Q2 FY27 (CONS.)

Net Profit: ₹8.01 Cr ↑233.07% YoY | ↓21.23% QoQ

Revenue: ₹82.29 Cr ↑395.50% YoY | ↑6.14% QoQ

EBITDA: ₹11.02 Cr ↑293.38% YoY | ↑2.05% QoQ

EBITDA Margin: 13.39% vs 16.87% YoY | 13.93% QoQ

NESCO Q2 FY27

Net Profit: ₹105 Cr ↓12% YoY | ↑5% QoQ

Revenue: ₹228 Cr ↓4% YoY | ↑8% QoQ

EBITDA: ₹128 Cr ↓6% YoY | ↑25% QoQ

EBITDA Margin: 56.0% vs 56.9% YoY | 48.3% QoQ

UNICOMMERCE Q2 FY27

Net Profit: ₹6 Cr ↑11% YoY | ↑37% QoQ

Revenue: ₹59 Cr ↑15% YoY | ↑15% QoQ

EBITDA: ₹9 Cr ↓6% YoY | ↑57% QoQ

EBITDA Margin: 14.5% vs 17.8% YoY | 10.6% QoQ

OFSS: Q2 REVENUE 19.1B RUPEES VS 17.9B (YOY)

OFSS: Q2 CONS NET PROFIT 7B RUPEES VS 5.5B (YOY); EST 7.4B

OFSS: Q2 EBITDA 9.26B RUPEES VS 7.55B (YOY); Q2 EBITDA MARGIN 48.55% VS 42.22% (YOY)

PERSISTENT SYSTEMS: CO SEES EBIT MARGIN ASPIRATION OF 16%-17%, TARGETS NAGARRO ACQUISITION CLOSURE BY Q4 CY26

US SEN. COLLINS: APPLE, SEAWEED, BLUEBERRY, POTATO PRODUCERS TO GET CANADA TARIFF RELIEF